| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 04/06/2005 | CN1604910A Affinity enhancement agents |
| 04/06/2005 | CN1603346A Protein, products containing same, and their use in diagnosis, treatment and /or prevention of SARS related disease |
| 04/06/2005 | CN1195858C OB fusion protein compositions and methods |
| 04/06/2005 | CN1195779C Double-specificity antibody resisting human ovary cancer and human CD3 |
| 04/05/2005 | US6875846 Heterologous polypeptide of the TNF family |
| 04/05/2005 | US6875845 Polypeptide for use in the treatment of cancer |
| 04/05/2005 | US6875590 Nucleotide sequences coding polypeptide for use as tools in genetic engineering |
| 03/31/2005 | WO2005028614A2 Construction of a gst-cbd fusion protein having several enzymatic activities |
| 03/31/2005 | WO2003103605A3 Flexible vaccine assembly and vaccine delivery platform |
| 03/31/2005 | US20050070691 Polypeptides of moraxella (branhamella) catarrhalis |
| 03/31/2005 | US20050070690 Producing tyrosine kinase receptor-related polypeptide for use in tools in identifying modulator for treatment of cell proliferative disorders; biosensors |
| 03/31/2005 | US20050070689 Nucleotide sequences coding transmembrane activator and CAML interactor (TACI) protein for use in treatment and prevention of autoimmune disorders |
| 03/31/2005 | US20050070002 Histidine phosphatase interacting protein with 120kd |
| 03/31/2005 | US20050069988 Recombinant expression systems for production of low solubility foreign proteins specifically aminoglobulin |
| 03/31/2005 | US20050069983 Nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatment of herpes viral infection, cell proliferative and autoimmune disorders |
| 03/31/2005 | US20050069944 Nucleotide sequences coding G-protein coupled receptor for use in identifying modulator of tase transduction; flavoring and food processing |
| 03/31/2005 | US20050069942 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 03/31/2005 | US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders. |
| 03/31/2005 | US20050069865 Synthetic hcv envelope proteins and their use for vaccination |
| 03/30/2005 | EP1518933A1 Vectors and methods for gene transfer to cells |
| 03/30/2005 | EP1517923A2 Compositions and methods for inhibiting microbial adhesion |
| 03/30/2005 | EP1517913A2 A mycobacterium tuberculosis coding sequence for exression of heterologous proteins |
| 03/30/2005 | EP1517700A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof |
| 03/30/2005 | EP1200105B1 Modified factor viii |
| 03/30/2005 | EP1124570A4 Novel neuropilin/growth factor binding and uses thereof |
| 03/30/2005 | CN1602358A Recombinant fusion proteins and the trimers thereof |
| 03/30/2005 | CN1602201A Peptides and related compounds having thrombopoietic activity |
| 03/30/2005 | CN1195063C Proteinase inhibitor fusion proteins |
| 03/30/2005 | CN1194991C Recombinant Toxoplasma fusion protein antigen and preparation process and use thereof |
| 03/29/2005 | US6872814 Chlamydia antigens and corresponding DNA fragments and uses thereof |
| 03/29/2005 | US6872551 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/29/2005 | US6872548 Polypeptide for use in animal models associated with human therapeutics |
| 03/29/2005 | US6872393 Polyalkylene oxide-modified single chain polypeptides |
| 03/24/2005 | WO2004043981A3 Nucleic acids and proteins with thioredoxin reductase activity |
| 03/24/2005 | US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders |
| 03/24/2005 | US20050064558 Chimeric polypeptide comprising functional differentially spliced interleukin receptor and b-cell differentiation factor for enhancing expression of interferon inducible protein (IP-10) and macrophage inflammarory proteins for use in treatment of viral diseases |
| 03/24/2005 | US20050064552 Genes containing a DNA sequence coding for hydroxynitrile lyase, recombinant proteins derived therefrom and having hydroxynitrile lyase activity, and use thereof |
| 03/24/2005 | US20050064543 Secreted proteins |
| 03/24/2005 | US20050064530 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 03/24/2005 | US20050064404 Regulation of human serotonin-like g protein-coupled receptor |
| 03/24/2005 | US20050063986 Process for the preparation of non-toxic anthrax vaccine |
| 03/24/2005 | US20050063984 Antigenic peptide fragments of vapa protein, and uses thereof |
| 03/24/2005 | US20050063970 An immunomolecule containing a soluble human Major Histocompatibility Complex class I effector domain linked to an antibody targeting domain; immunotherapy; anticarcinogenic agents |
| 03/24/2005 | CA2526720A1 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 03/23/2005 | EP1516932A1 Poxvirus with targeted infection specificity |
| 03/23/2005 | EP1516928A1 Expression vector, host, fused protein, process for producing fused protein and process for producing protein |
| 03/23/2005 | EP1515990A2 Antagonists of cxcr3-binding cxc chemokines |
| 03/23/2005 | EP1515989A1 Immunogenic conjugates |
| 03/23/2005 | EP1515982A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 03/23/2005 | CN1599867A Immunocytokines with modulated selectivity |
| 03/23/2005 | CN1597698A Cation antibacterial peptide |
| 03/23/2005 | CN1194017C Novel antibody, renin-active substance containing same and prorenin assay reagent using the same |
| 03/22/2005 | US6870033 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies |
| 03/22/2005 | CA2103059C Method for making humanized antibodies |
| 03/17/2005 | US20050059577 Glycosylphosphatidylinositol containing polypeptides |
| 03/17/2005 | US20050059121 Colony stimualting factor for use in animal vaccination and as nonspecific immunity stimulant; veterinary medicine |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050059058 Oligonucleotide sequences coding integral membrane proteins (ZIPA) for use as tool in identifying bactericidal agents; microbiocides; drug screening |
| 03/17/2005 | US20050058647 Newly identified polypeptide and polynucleotides for diagnosis of new compounds |
| 03/16/2005 | EP1514934A2 Biosynthetic binding protein for cancer marker |
| 03/16/2005 | EP1514925A1 Method of screening compound affecting amyloid beta production |
| 03/16/2005 | EP1514876A2 Antibody against prostate stem cell antigen (PSCA) |
| 03/16/2005 | EP1513879A2 Synthetic antibody phage libraries |
| 03/16/2005 | EP1513860A2 P450 enzymes, nucleic acids encoding them and methods of making and using them |
| 03/16/2005 | EP1513554A1 Cd16a binding proteins and use for the treatment of immune disorders |
| 03/16/2005 | EP1456241B1 Mono-and dual anti-cd4-rantes chemokine/cytokine constructs |
| 03/16/2005 | CN1596371A Novel self-assembly molecules |
| 03/16/2005 | CN1596304A Protein knobs |
| 03/16/2005 | CN1596266A Specific binding agents of human angiopoietin-2 |
| 03/16/2005 | CN1594578A Sea anemone neurotoxin gene Sr3 and application thereof |
| 03/16/2005 | CN1594577A Sea anemone neurotoxin gene Sr4 and application thereof |
| 03/16/2005 | CN1594576A Sea anemone neurotoxin gene Sr5 and application thereof |
| 03/16/2005 | CN1594575A Sea anemone neurotoxin gene Sr6 and application thereof |
| 03/16/2005 | CN1594574A Sea anemone neurotoxin gene Sr2 and application thereof |
| 03/16/2005 | CN1594573A Sea anemone neurotoxin gene Sr1 and application thereof |
| 03/16/2005 | CN1594572A Sea anemone neurotoxin gene Sr7 and application thereof |
| 03/16/2005 | CN1594359A Hepatitis B vaccine and its preparation method |
| 03/16/2005 | CN1193042C C-peptide for the improved production of insulin and insulin analogues |
| 03/16/2005 | CN1192799C Adjuvant combination formulations |
| 03/15/2005 | US6866851 GFRα1-RET specific agonists and methods therefor |
| 03/10/2005 | WO2003085089A3 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 03/10/2005 | US20050054820 Expression vector comprising nucleotide sequences coding calreticulin/heat shock protein fusion for use as tool in enhancement and induction of major histocompatibility complex immunological response; immunotherapy; tissue targeted therapy |
| 03/10/2005 | US20050054593 New drug |
| 03/10/2005 | US20050054050 Green fluorescent protein for use as diagnostic indicator of genic expression in transformed cells; genetic engineering |
| 03/10/2005 | US20050054046 Evaluating safety, efficacy and biological properties of immunoglobulin receptors; immunotherapeutic agents |
| 03/10/2005 | US20050054034 Polypeptide encoding by a polynucleotide; for detecting diseases; use in diagnosis and in identifying compounds that may be agonists, antagonists as biodrug treating diseases; host cell culturing |
| 03/10/2005 | CA2535856A1 Fusion polypeptides, and use thereof in antivascular tumor therapy |
| 03/10/2005 | CA2535526A1 Laccases, nucleic acids encoding them and methods for making and using them |
| 03/09/2005 | EP1512696A1 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei |
| 03/09/2005 | EP1512008A1 Use of corticotroph-derived glycoprotein hormone to treat inflammation and potentiate glucocorticoid action |
| 03/09/2005 | EP1511846A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence |
| 03/09/2005 | EP1511770A2 Immunoadhesin comprising a glycoprotein vi domain |
| 03/09/2005 | EP1511480A2 Inhibitors of glycoprotein vi |
| 03/09/2005 | EP1392354B1 Use of alpha-1 antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic wounds |
| 03/09/2005 | EP1233783B1 Hbv/hcv virus-like particle |
| 03/09/2005 | EP0938556B1 Gamma-heregulin |
| 03/09/2005 | EP0842273B1 Receptor ligand vegf-c |
| 03/09/2005 | CN1590543A Thermostable Taq polymerase fragment |
| 03/09/2005 | CN1590407A Multifunctional blood forming receptor agonist |
| 03/09/2005 | CN1192109C Anticoagulant fusion protein anchored to cell membrane |